’Shrooms Lead the Pack in Psychedelic Medicine, but Rollout Is Bumpy
Psilocybin-assisted therapy is legal in three states, but access has so far been limited and expensive. In the billion-dollar race to commercialize psychedelic medicine, psilocybin, a naturally ...
The Business Journals
FDA rejects Peninsula company's rare disease drug, sending stock to $4 billion-plus selloff
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The same drug is under FDA ...
Nasdaq
Corcept Stock Plunges 50% After FDA Rejects Relacorilant Application
(RTTNews) - Corcept Therapeutics Incorporated (CORT) shares fell 50.50%, trading at $34.74, down $35.45, after the company announced it received a Complete Response Letter (CRL) from the U.S. Food and ...
Benzinga.com
Corcept Therapeutics Stock Sinks On FDA Setback For Relacorilant
Corcept Therapeutics Incorporated (NASDAQ: CORT) stock tumbled Wednesday after the FDA rejection for relacorilant. The commercial-stage company is engaged in the discovery and development of ...
The Media Line
A Psychedelic Pivot: Israel Tests MDMA in Group Sessions To Tackle PTSD
Maayan Hoffman reports that Israel’s post-Oct. 7 mental health crunch is colliding with a hard reality: there aren’t enough clinicians to meet soaring demand. A new study launching with Sheba Medical ...
The Media Line
Could a Psychedelic Breakthrough Expand Trauma Care in Israel?
State Comptroller Matanyahu Englman said that in the aftermath of the Oct. 7 Hamas-led massacre and the subsequent war, approximately 3 million adults in Israel experienced anxiety, depression, or ...
The New York Times
Why Russia Is Likely to Reject the New U.S.-Ukrainian Peace Plan
The first draft essentially called for Ukraine’s surrender. The revised version includes the security guarantees Kyiv wants to prevent future Russian aggression. By Ivan Nechepurenko On Tuesday, ...
High Times
The U.S. Military Is Funding MDMA-Assisted Therapy Research for PTSD (For Real)
A Department of Defense (DoD)-funded clinical trial will study MDMA-assisted therapy paired with Massed Prolonged Exposure for PTSD in active-duty service members. While MDMA-assisted therapy has been ...
ABC News
FDA approves Wegovy pill for weight loss: What to know
Some tout a daily semaglutide pill as a game-changer for weight-loss treatment. The Food and Drug Administration has approved the first GLP-1 pill for weight loss and maintenance. Drugmaker Novo ...
Forbes
FDA Approves Pill Version Of Novo Nordisk’s Wegovy—A First For GLP-1s
The pill version of Novo Nordisk’s weight loss treatment Wegovy received Food and Drug Administration approval Monday, marking the first oral GLP-1 medication that will soon hit the market. The ...
KJZZ
Sinema praises MAHA movement for supporting research into PTSD therapy ibogaine
Arizona’s current budget allocates $5 million for research into the potential medical benefits of ibogaine, a psychedelic derived from an African root. Advocates, like former U.S. Sen. Kyrsten Sinema, ...